 | • レポートコード：MRC2-11QY04017 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は心臓核医学のグローバル市場について調査・分析したレポートです。種類別（放射線機器、放射線情報システム（RIS）、放射線医薬品）市場規模、用途別（病院、診療所、学術研究機関、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別心臓核医学の競争状況、市場シェア ・世界の心臓核医学市場：種類別市場規模 2015年-2020年（放射線機器、放射線情報システム（RIS）、放射線医薬品） ・世界の心臓核医学市場：種類別市場規模予測 2021年-2026年（放射線機器、放射線情報システム（RIS）、放射線医薬品） ・世界の心臓核医学市場：用途別市場規模 2015年-2020年（病院、診療所、学術研究機関、その他） ・世界の心臓核医学市場：用途別市場規模予測 2021年-2026年（病院、診療所、学術研究機関、その他） ・北米の心臓核医学市場分析：米国、カナダ ・ヨーロッパの心臓核医学市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの心臓核医学市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の心臓核医学市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの心臓核医学市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：GE Healthcare、Shimadzu、Siemens Healthcare、Fujifilm Medical、Astellas Pharma、Philips Healthcare、Medtronic、3mensio Medical Imaging、Bracco Diagnostics、UltraSPECT ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Nuclear imaging in cardiac disorders aids in accurate diagnosis of cardiovascular diseases and blockages in blood flow. Nuclear imaging is a technique for producing images of various body parts utilizing radioactive materials. This technique has applications in diagnosis of various cardiovascular diseases such as angina, aneurysm, atherosclerosis, stroke, coronary artery disease and congestive heart failure. Accurate diagnosis of such chronic diseases is essential to plan precise and cost-effective therapeutic module.
Geographically, this market is categorized into North America, Europe, Asia-Pacific and Rest of the World. Better capacities to handle new and highly advanced technologies have kept North America ahead of the other regions in terms of the nuclear cardiology market. However, catering to the untapped opportunities in the Asia-Pacific and Latin American regions will drive these regions at a faster growth rate.
Market Analysis and Insights: Global Nuclear Cardiology Market
The global Nuclear Cardiology market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Nuclear Cardiology Scope and Market Size
Nuclear Cardiology market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Nuclear Cardiology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
GE Healthcare
Shimadzu
Siemens Healthcare
Fujifilm Medical
Astellas Pharma
Philips Healthcare
Medtronic
3mensio Medical Imaging
Bracco Diagnostics
UltraSPECT
Market segment by Type, the product can be split into
Radiology Devices
Radiology Information Systems (RIS)
Radiopharmaceuticals
Market segment by Application, split into
Hospitals
Clinics
Academic and Research Institutes
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Nuclear Cardiology Revenue
1.4 Market by Type
1.4.1 Global Nuclear Cardiology Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Radiology Devices
1.4.3 Radiology Information Systems (RIS)
1.4.4 Radiopharmaceuticals
1.5 Market by Application
1.5.1 Global Nuclear Cardiology Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Academic and Research Institutes
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Nuclear Cardiology Market Perspective (2015-2026)
2.2 Global Nuclear Cardiology Growth Trends by Regions
2.2.1 Nuclear Cardiology Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Nuclear Cardiology Historic Market Share by Regions (2015-2020)
2.2.3 Nuclear Cardiology Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Nuclear Cardiology Market Growth Strategy
2.3.6 Primary Interviews with Key Nuclear Cardiology Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Nuclear Cardiology Players by Market Size
3.1.1 Global Top Nuclear Cardiology Players by Revenue (2015-2020)
3.1.2 Global Nuclear Cardiology Revenue Market Share by Players (2015-2020)
3.1.3 Global Nuclear Cardiology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Nuclear Cardiology Market Concentration Ratio
3.2.1 Global Nuclear Cardiology Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Nuclear Cardiology Revenue in 2019
3.3 Nuclear Cardiology Key Players Head office and Area Served
3.4 Key Players Nuclear Cardiology Product Solution and Service
3.5 Date of Enter into Nuclear Cardiology Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Nuclear Cardiology Historic Market Size by Type (2015-2020)
4.2 Global Nuclear Cardiology Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Nuclear Cardiology Market Size by Application (2015-2020)
5.2 Global Nuclear Cardiology Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Nuclear Cardiology Market Size (2015-2020)
6.2 Nuclear Cardiology Key Players in North America (2019-2020)
6.3 North America Nuclear Cardiology Market Size by Type (2015-2020)
6.4 North America Nuclear Cardiology Market Size by Application (2015-2020)
7 Europe
7.1 Europe Nuclear Cardiology Market Size (2015-2020)
7.2 Nuclear Cardiology Key Players in Europe (2019-2020)
7.3 Europe Nuclear Cardiology Market Size by Type (2015-2020)
7.4 Europe Nuclear Cardiology Market Size by Application (2015-2020)
8 China
8.1 China Nuclear Cardiology Market Size (2015-2020)
8.2 Nuclear Cardiology Key Players in China (2019-2020)
8.3 China Nuclear Cardiology Market Size by Type (2015-2020)
8.4 China Nuclear Cardiology Market Size by Application (2015-2020)
9 Japan
9.1 Japan Nuclear Cardiology Market Size (2015-2020)
9.2 Nuclear Cardiology Key Players in Japan (2019-2020)
9.3 Japan Nuclear Cardiology Market Size by Type (2015-2020)
9.4 Japan Nuclear Cardiology Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Nuclear Cardiology Market Size (2015-2020)
10.2 Nuclear Cardiology Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Nuclear Cardiology Market Size by Type (2015-2020)
10.4 Southeast Asia Nuclear Cardiology Market Size by Application (2015-2020)
11 India
11.1 India Nuclear Cardiology Market Size (2015-2020)
11.2 Nuclear Cardiology Key Players in India (2019-2020)
11.3 India Nuclear Cardiology Market Size by Type (2015-2020)
11.4 India Nuclear Cardiology Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Nuclear Cardiology Market Size (2015-2020)
12.2 Nuclear Cardiology Key Players in Central & South America (2019-2020)
12.3 Central & South America Nuclear Cardiology Market Size by Type (2015-2020)
12.4 Central & South America Nuclear Cardiology Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 GE Healthcare
13.1.1 GE Healthcare Company Details
13.1.2 GE Healthcare Business Overview
13.1.3 GE Healthcare Nuclear Cardiology Introduction
13.1.4 GE Healthcare Revenue in Nuclear Cardiology Business (2015-2020))
13.1.5 GE Healthcare Recent Development
13.2 Shimadzu
13.2.1 Shimadzu Company Details
13.2.2 Shimadzu Business Overview
13.2.3 Shimadzu Nuclear Cardiology Introduction
13.2.4 Shimadzu Revenue in Nuclear Cardiology Business (2015-2020)
13.2.5 Shimadzu Recent Development
13.3 Siemens Healthcare
13.3.1 Siemens Healthcare Company Details
13.3.2 Siemens Healthcare Business Overview
13.3.3 Siemens Healthcare Nuclear Cardiology Introduction
13.3.4 Siemens Healthcare Revenue in Nuclear Cardiology Business (2015-2020)
13.3.5 Siemens Healthcare Recent Development
13.4 Fujifilm Medical
13.4.1 Fujifilm Medical Company Details
13.4.2 Fujifilm Medical Business Overview
13.4.3 Fujifilm Medical Nuclear Cardiology Introduction
13.4.4 Fujifilm Medical Revenue in Nuclear Cardiology Business (2015-2020)
13.4.5 Fujifilm Medical Recent Development
13.5 Astellas Pharma
13.5.1 Astellas Pharma Company Details
13.5.2 Astellas Pharma Business Overview
13.5.3 Astellas Pharma Nuclear Cardiology Introduction
13.5.4 Astellas Pharma Revenue in Nuclear Cardiology Business (2015-2020)
13.5.5 Astellas Pharma Recent Development
13.6 Philips Healthcare
13.6.1 Philips Healthcare Company Details
13.6.2 Philips Healthcare Business Overview
13.6.3 Philips Healthcare Nuclear Cardiology Introduction
13.6.4 Philips Healthcare Revenue in Nuclear Cardiology Business (2015-2020)
13.6.5 Philips Healthcare Recent Development
13.7 Medtronic
13.7.1 Medtronic Company Details
13.7.2 Medtronic Business Overview
13.7.3 Medtronic Nuclear Cardiology Introduction
13.7.4 Medtronic Revenue in Nuclear Cardiology Business (2015-2020)
13.7.5 Medtronic Recent Development
13.8 3mensio Medical Imaging
13.8.1 3mensio Medical Imaging Company Details
13.8.2 3mensio Medical Imaging Business Overview
13.8.3 3mensio Medical Imaging Nuclear Cardiology Introduction
13.8.4 3mensio Medical Imaging Revenue in Nuclear Cardiology Business (2015-2020)
13.8.5 3mensio Medical Imaging Recent Development
13.9 Bracco Diagnostics
13.9.1 Bracco Diagnostics Company Details
13.9.2 Bracco Diagnostics Business Overview
13.9.3 Bracco Diagnostics Nuclear Cardiology Introduction
13.9.4 Bracco Diagnostics Revenue in Nuclear Cardiology Business (2015-2020)
13.9.5 Bracco Diagnostics Recent Development
13.10 UltraSPECT
13.10.1 UltraSPECT Company Details
13.10.2 UltraSPECT Business Overview
13.10.3 UltraSPECT Nuclear Cardiology Introduction
13.10.4 UltraSPECT Revenue in Nuclear Cardiology Business (2015-2020)
13.10.5 UltraSPECT Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Nuclear Cardiology Key Market Segments
Table 2. Key Players Covered: Ranking by Nuclear Cardiology Revenue
Table 3. Ranking of Global Top Nuclear Cardiology Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Nuclear Cardiology Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Radiology Devices
Table 6. Key Players of Radiology Information Systems (RIS)
Table 7. Key Players of Radiopharmaceuticals
Table 8. Global Nuclear Cardiology Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Nuclear Cardiology Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Nuclear Cardiology Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Nuclear Cardiology Market Share by Regions (2015-2020)
Table 12. Global Nuclear Cardiology Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Nuclear Cardiology Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Nuclear Cardiology Market Growth Strategy
Table 18. Main Points Interviewed from Key Nuclear Cardiology Players
Table 19. Global Nuclear Cardiology Revenue by Players (2015-2020) (Million US$)
Table 20. Global Nuclear Cardiology Market Share by Players (2015-2020)
Table 21. Global Top Nuclear Cardiology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Cardiology as of 2019)
Table 22. Global Nuclear Cardiology by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Nuclear Cardiology Product Solution and Service
Table 25. Date of Enter into Nuclear Cardiology Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Nuclear Cardiology Market Size by Type (2015-2020) (Million US$)
Table 28. Global Nuclear Cardiology Market Size Share by Type (2015-2020)
Table 29. Global Nuclear Cardiology Revenue Market Share by Type (2021-2026)
Table 30. Global Nuclear Cardiology Market Size Share by Application (2015-2020)
Table 31. Global Nuclear Cardiology Market Size by Application (2015-2020) (Million US$)
Table 32. Global Nuclear Cardiology Market Size Share by Application (2021-2026)
Table 33. North America Key Players Nuclear Cardiology Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Nuclear Cardiology Market Share (2019-2020)
Table 35. North America Nuclear Cardiology Market Size by Type (2015-2020) (Million US$)
Table 36. North America Nuclear Cardiology Market Share by Type (2015-2020)
Table 37. North America Nuclear Cardiology Market Size by Application (2015-2020) (Million US$)
Table 38. North America Nuclear Cardiology Market Share by Application (2015-2020)
Table 39. Europe Key Players Nuclear Cardiology Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Nuclear Cardiology Market Share (2019-2020)
Table 41. Europe Nuclear Cardiology Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Nuclear Cardiology Market Share by Type (2015-2020)
Table 43. Europe Nuclear Cardiology Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Nuclear Cardiology Market Share by Application (2015-2020)
Table 45. China Key Players Nuclear Cardiology Revenue (2019-2020) (Million US$)
Table 46. China Key Players Nuclear Cardiology Market Share (2019-2020)
Table 47. China Nuclear Cardiology Market Size by Type (2015-2020) (Million US$)
Table 48. China Nuclear Cardiology Market Share by Type (2015-2020)
Table 49. China Nuclear Cardiology Market Size by Application (2015-2020) (Million US$)
Table 50. China Nuclear Cardiology Market Share by Application (2015-2020)
Table 51. Japan Key Players Nuclear Cardiology Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Nuclear Cardiology Market Share (2019-2020)
Table 53. Japan Nuclear Cardiology Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Nuclear Cardiology Market Share by Type (2015-2020)
Table 55. Japan Nuclear Cardiology Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Nuclear Cardiology Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Nuclear Cardiology Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Nuclear Cardiology Market Share (2019-2020)
Table 59. Southeast Asia Nuclear Cardiology Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Nuclear Cardiology Market Share by Type (2015-2020)
Table 61. Southeast Asia Nuclear Cardiology Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Nuclear Cardiology Market Share by Application (2015-2020)
Table 63. India Key Players Nuclear Cardiology Revenue (2019-2020) (Million US$)
Table 64. India Key Players Nuclear Cardiology Market Share (2019-2020)
Table 65. India Nuclear Cardiology Market Size by Type (2015-2020) (Million US$)
Table 66. India Nuclear Cardiology Market Share by Type (2015-2020)
Table 67. India Nuclear Cardiology Market Size by Application (2015-2020) (Million US$)
Table 68. India Nuclear Cardiology Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Nuclear Cardiology Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Nuclear Cardiology Market Share (2019-2020)
Table 71. Central & South America Nuclear Cardiology Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Nuclear Cardiology Market Share by Type (2015-2020)
Table 73. Central & South America Nuclear Cardiology Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Nuclear Cardiology Market Share by Application (2015-2020)
Table 75. GE Healthcare Company Details
Table 76. GE Healthcare Business Overview
Table 77. GE Healthcare Product
Table 78. GE Healthcare Revenue in Nuclear Cardiology Business (2015-2020) (Million US$)
Table 79. GE Healthcare Recent Development
Table 80. Shimadzu Company Details
Table 81. Shimadzu Business Overview
Table 82. Shimadzu Product
Table 83. Shimadzu Revenue in Nuclear Cardiology Business (2015-2020) (Million US$)
Table 84. Shimadzu Recent Development
Table 85. Siemens Healthcare Company Details
Table 86. Siemens Healthcare Business Overview
Table 87. Siemens Healthcare Product
Table 88. Siemens Healthcare Revenue in Nuclear Cardiology Business (2015-2020) (Million US$)
Table 89. Siemens Healthcare Recent Development
Table 90. Fujifilm Medical Company Details
Table 91. Fujifilm Medical Business Overview
Table 92. Fujifilm Medical Product
Table 93. Fujifilm Medical Revenue in Nuclear Cardiology Business (2015-2020) (Million US$)
Table 94. Fujifilm Medical Recent Development
Table 95. Astellas Pharma Company Details
Table 96. Astellas Pharma Business Overview
Table 97. Astellas Pharma Product
Table 98. Astellas Pharma Revenue in Nuclear Cardiology Business (2015-2020) (Million US$)
Table 99. Astellas Pharma Recent Development
Table 100. Philips Healthcare Company Details
Table 101. Philips Healthcare Business Overview
Table 102. Philips Healthcare Product
Table 103. Philips Healthcare Revenue in Nuclear Cardiology Business (2015-2020) (Million US$)
Table 104. Philips Healthcare Recent Development
Table 105. Medtronic Company Details
Table 106. Medtronic Business Overview
Table 107. Medtronic Product
Table 108. Medtronic Revenue in Nuclear Cardiology Business (2015-2020) (Million US$)
Table 109. Medtronic Recent Development
Table 110. 3mensio Medical Imaging Business Overview
Table 111. 3mensio Medical Imaging Product
Table 112. 3mensio Medical Imaging Company Details
Table 113. 3mensio Medical Imaging Revenue in Nuclear Cardiology Business (2015-2020) (Million US$)
Table 114. 3mensio Medical Imaging Recent Development
Table 115. Bracco Diagnostics Company Details
Table 116. Bracco Diagnostics Business Overview
Table 117. Bracco Diagnostics Product
Table 118. Bracco Diagnostics Revenue in Nuclear Cardiology Business (2015-2020) (Million US$)
Table 119. Bracco Diagnostics Recent Development
Table 120. UltraSPECT Company Details
Table 121. UltraSPECT Business Overview
Table 122. UltraSPECT Product
Table 123. UltraSPECT Revenue in Nuclear Cardiology Business (2015-2020) (Million US$)
Table 124. UltraSPECT Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nuclear Cardiology Market Share by Type: 2020 VS 2026
Figure 2. Radiology Devices Features
Figure 3. Radiology Information Systems (RIS) Features
Figure 4. Radiopharmaceuticals Features
Figure 5. Global Nuclear Cardiology Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Academic and Research Institutes Case Studies
Figure 9. Others Case Studies
Figure 10. Nuclear Cardiology Report Years Considered
Figure 11. Global Nuclear Cardiology Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Nuclear Cardiology Market Share by Regions: 2020 VS 2026
Figure 13. Global Nuclear Cardiology Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Nuclear Cardiology Market Share by Players in 2019
Figure 16. Global Top Nuclear Cardiology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Cardiology as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Nuclear Cardiology Revenue in 2019
Figure 18. North America Nuclear Cardiology Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Nuclear Cardiology Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Nuclear Cardiology Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Nuclear Cardiology Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Nuclear Cardiology Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Nuclear Cardiology Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Nuclear Cardiology Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
インターベンショナルカーディオロジー装置の世界市場（～2026年） Interventional cardiology is numerous non-surgical processes for treating cardiovascular related problems. These procedures use flexible tubes and catheters thin to get way inside blood vessels to perform diagnostic test or to repair heart structures or other damaged vessels, often evading the need …- 改修心臓血管及び心臓病用機器の世界市場（～2026年） Market Analysis and Insights: Global Refurbished Cardiovascular & Cardiology Equipment Market The global Refurbished Cardiovascular & Cardiology Equipment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Refurbished Car…
- 心臓手術・装置・薬剤の世界市場（～2026年） Cardiology is a branch of medicine dealing with disorders of the heart as well as parts of the circulatory system. One of the major factors driving the market is medical tourism. Market Analysis and Insights: Global Cardiology Surgery, Devices and Drugs Market The global Cardiology Surgery, Devices …
- 小児放射線の世界市場（～2026年） Pediatric radiology is a subspecialty of radiology involving the imaging of fetuses, infants, children, adolescents and young adults. The key factor contributing to the pediatric radiology market is the increasing incidence of diagnosis. Market Analysis and Insights: Global Pediatric Radiology Marke…
- 心臓ポイントオブケア（POC）診断の世界市場（～2026年） Market Analysis and Insights: Global Cardiology Point-of-Care (POC) Diagnostics Market The global Cardiology Point-of-Care (POC) Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cardiology Point-of-Care (POC…